{"DataElement":{"publicId":"2748795","version":"2","preferredName":"Malignant Cell Removed Method Type","preferredDefinition":"A description of any method used to remove malignant cells.","longName":"MAL_CEL_REMV_MED_TY","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2748774","version":"1","preferredName":"Malignant Cell Removed Method","preferredDefinition":"Cells of, or derived from, a malignant tumor._Taken out of, separated from, or eliminated._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"MALIG_CELL_REMOV_MED","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2794106","version":"1","preferredName":"Malignant Cell Removed","preferredDefinition":"Cells of, or derived from, a malignant tumor.:Removed; taken out of or separated from.","longName":"C12917:C25650","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Cell","conceptCode":"C12917","definition":"Cells of, or derived from, a malignant tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Removed","conceptCode":"C25650","definition":"Taken out of, separated from, or eliminated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59744E3C-5AE6-2E80-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-17","modifiedBy":"ONEDATA","dateModified":"2008-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2730351","version":"1","preferredName":"Method","preferredDefinition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4692C84F-EB01-324C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"ONEDATA","dateModified":"2008-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0B55F9-95BD-227F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-12","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2748750","version":"1.1","preferredName":"Malignant Cell Removed Method Type","preferredDefinition":"Cells of, or derived from, a malignant tumor._Taken out of, separated from, or eliminated._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.","longName":"REMV_MALI_CEL_MED_TY","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Immunomagnetic column","valueDescription":"Immunomagnetic Column","ValueMeaning":{"publicId":"2748752","version":"1","preferredName":"Immunomagnetic Column","longName":"2748752","preferredDefinition":"A separation column that when placed in proximity to a magnet creates a high gradient magnetic field strong enough to retain cells labeled with antibodies complexed to magnetic particles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunomagnetic Column","conceptCode":"C71606","definition":"A separation column that when placed in proximity to a magnet creates a high gradient magnetic field strong enough to retain cells labeled with antibodies complexed to magnetic particles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0A51E0-6355-1FEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-5898-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Elutriation","valueDescription":"Elutriative Centrifugation","ValueMeaning":{"publicId":"2743430","version":"1","preferredName":"Elutriative Centrifugation","longName":"2743430","preferredDefinition":"Separation of particles on the basis of their differential sedimentation rate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elutriative Centrifugation","conceptCode":"C18798","definition":"Separation of particles on the basis of their differential sedimentation rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B2C4B25-800D-5607-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-58A2-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Other drug","valueDescription":"Other Medication","ValueMeaning":{"publicId":"2748753","version":"1","preferredName":"Other Medication","longName":"2748753","preferredDefinition":"Not otherwise specified.: biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0A51E0-6386-1FEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-58AC-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Mafosfamide","valueDescription":"Mafosfamide","ValueMeaning":{"publicId":"2748755","version":"1","preferredName":"Mafosfamide","longName":"2748755","preferredDefinition":"A form of cyclophosphamide that can be administered as an intrathecal infusion.  Mafosfamide is being studied as an anticancer drug.  It belongs to the family of drugs called alkylating agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mafosfamide","conceptCode":"C1150","definition":"A synthetic oxazaphosphorine derivative with antineoplastic properties.  Mafosfamide alkylates DNA, forming DNA cross-links and inhibiting DNA synthesis.  Although closely related to cyclophosphamide, mafosfamide, unlike cyclophosphamide, does not require hepatic activation to generate its active metabolite 4-hydroxy-cyclophosphamide; accordingly, mafosfamide is potentially useful in the intrathecal treatment of neoplastic meningitis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0A51E0-63AE-1FEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-58B6-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"4-hydroperoxycyclophosphamide (4HC)","valueDescription":"Perfosfamide","ValueMeaning":{"publicId":"2748757","version":"1","preferredName":"Perfosfamide","longName":"2748757","preferredDefinition":"The active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perfosfamide","conceptCode":"C1423","definition":"The active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0A51E0-63D6-1FEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-5926-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Other method","valueDescription":"Other Method","ValueMeaning":{"publicId":"3288146","version":"1","preferredName":"Other Method","longName":"3288146","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE686AB8-616F-74D6-E040-BB89AD436198","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-593A-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Toxin","valueDescription":"Toxin","ValueMeaning":{"publicId":"2748751","version":"1","preferredName":"Toxin","longName":"2748751","preferredDefinition":"Poisons produced by certain animals, plants, or bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxin","conceptCode":"C894","definition":"A chemical, physical, or biological agent that causes disease or some alteration of the normal structure and function of an organism. Usually refers to poisonous substance produced during the metabolism and growth of certain microorganisms and some higher plant and animal species, or any poisonous isomer, homolog, or derivative of such a substance. It causes either permanent or reversible injury to the health of a living thing on contact or absorption, typically by interacting with biological macromolecules such as enzymes and receptors. Onset of effects may be immediate or delayed, and impairments may be slight or severe. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0A51E0-632E-1FEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-58D4-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"CD34 selection","valueDescription":"Hematopoietic Stem Cell Positive Selection","ValueMeaning":{"publicId":"2797408","version":"1","preferredName":"Hematopoietic Stem Cell Positive Selection","longName":"2797408","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): The separation of specific cells or cell populations from a heterogeneous mixture. Specifically it refers to the selective retention of a population of desired cells through recognition of cells bearing the specified characteristics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Selection","conceptCode":"C71257","definition":"The selective retention of a population of desired cells through recognition of cells bearing specific characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AE36AA5-C5A9-61CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EBB14F9D-594E-DF5B-E040-BB89AD4373E7","beginDate":"2008-11-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"},{"value":"Monoclonal antibody","valueDescription":"Monoclonal Antibody","ValueMeaning":{"publicId":"2829937","version":"1","preferredName":"Monoclonal Antibody","longName":"2829937","preferredDefinition":"An antibody produced by a clone or genetically homogenous population of hybrid cells i.e., hybridoma; hybrid cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis and treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monoclonal Antibody","conceptCode":"C20401","definition":"An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"618DC679-B100-32DD-E040-BB89AD43461A","latestVersionIndicator":"Yes","beginDate":"2009-01-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"EBB14F9D-59D0-DF5B-E040-BB89AD4373E7","beginDate":"2008-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ONEDATA","dateModified":"2013-11-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2797407","version":"1","preferredName":"Malignant Cell Removed Method Type","preferredDefinition":"Cells of, or derived from, a malignant tumor.:Removed; taken out of or separated from.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Type; a subdivision of a particular kind of thing.","longName":"C12917:C25650:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Cell","conceptCode":"C12917","definition":"Cells of, or derived from, a malignant tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Removed","conceptCode":"C25650","definition":"Taken out of, separated from, or eliminated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AE36AA5-C591-61CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-04","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-11-04","modifiedBy":"ONEDATA","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBB14F9D-5877-DF5B-E040-BB89AD4373E7","latestVersionIndicator":"Yes","beginDate":"2013-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"NYCHM","dateModified":"2015-08-18","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964920","version":"1","longName":"2006r1: HSCT Infusion","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842913","version":"1","longName":"Best Response","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"DefinedProcedure:methodCode","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What malignant cell removal m","type":"Preferred Question Text","description":"What malignant cell removal method was used?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2748795","type":"BRIDG Mapping Path","description":"PerformedSubstanceAdministration [DCI] > StudyAgent > Biologic > Subject [Stem Cells] > PerformedProcedure > DefinedProcedure.methodCode WHERE PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Donor Cellular Infusion(DCI)\" AND DefinedProcedure.nameCode = \"Perform Autologous Malignant Cell Removal\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBB14F9D-5958-DF5B-E040-BB89AD4373E7","latestVersionIndicator":"Yes","beginDate":"2013-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-21","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}